Olaparib API
| Name of Product | Olaparib |
|---|---|
| CAS No | 763113‑22‑0 |
| Therapeutic use:- | PARP inhibitor – for ovarian, breast, pancreatic & prostate cancers |
| Grade | IH |
| Form:- | API Powder |
| Status | Regular |
Product Overview
Olaparib is a chemical that prevents cancer. It is used to develop medicines for various tumors. It is a class of medicines known as PARP inhibitors. They inhibit the PARP enzyme, which repairs broken DNA within cells. When DNA cannot be repaired, cancer cells cease to reproduce and die. This, in turn, qualifies Olaparib as a brilliant or “targeted” medicine. It selectively hits cancer cells more intensely than normal cells. Since it is stable as well as pure, pharmaceutical manufacturers prefer it for predictable as well as powerful outcomes.
Therapeutic Applications
Olaparib treats cancers that are associated with defective BRCA1 or BRCA2 genes. They usually repair DNA, but if they don’t, cancers develop. Olaparib prevents this from occurring.
Physicians like Olaparib as it comes as a pill, which patients prefer over injections, and it causes milder side effects compared to older drugs. It has increased survival and quality of life for numerous patients.
Specification Parameters
Every lot adheres to international quality and safety guidelines. It’s prepared under cGMP and ICH Q7 guidelines. Reports for analysis, such as HPLC, IR, and NMR, are provided for assurance of purity as well as structure.
Packaging & Storage
Olaparib API is packed safely to keep it dry and clean. Store it below 25°C, in a cool and dry place. Keep away from direct light and damp air. Always wear gloves and protective clothing while handling. It usually comes in:
Why Choose Actiza Pharma
Actiza Pharmaceuticals provides reliable and high-quality API production. It produces Olaparib and other oncology APIs under strict quality and safety regimes.